Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP455470.RAFHG00pkcoKADfRNHvEqw8uHcCCfFrBJp9S6t09En5nw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP455470.RAFHG00pkcoKADfRNHvEqw8uHcCCfFrBJp9S6t09En5nw130_assertion type Assertion NP455470.RAFHG00pkcoKADfRNHvEqw8uHcCCfFrBJp9S6t09En5nw130_head.
- NP455470.RAFHG00pkcoKADfRNHvEqw8uHcCCfFrBJp9S6t09En5nw130_assertion description "[The multidrug-resistance (MR) status of camptothecin (CPT) was investigated in colon adenocarcinoma HT29 cells, leukemia K562, and breast carcinoma MCF7 cells expressing P-glycoprotein (Pgp) and/or MR-associated protein (MRP1).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP455470.RAFHG00pkcoKADfRNHvEqw8uHcCCfFrBJp9S6t09En5nw130_provenance.
- NP455470.RAFHG00pkcoKADfRNHvEqw8uHcCCfFrBJp9S6t09En5nw130_assertion evidence source_evidence_literature NP455470.RAFHG00pkcoKADfRNHvEqw8uHcCCfFrBJp9S6t09En5nw130_provenance.
- NP455470.RAFHG00pkcoKADfRNHvEqw8uHcCCfFrBJp9S6t09En5nw130_assertion SIO_000772 12115804 NP455470.RAFHG00pkcoKADfRNHvEqw8uHcCCfFrBJp9S6t09En5nw130_provenance.
- NP455470.RAFHG00pkcoKADfRNHvEqw8uHcCCfFrBJp9S6t09En5nw130_assertion wasDerivedFrom befree-20140225 NP455470.RAFHG00pkcoKADfRNHvEqw8uHcCCfFrBJp9S6t09En5nw130_provenance.
- NP455470.RAFHG00pkcoKADfRNHvEqw8uHcCCfFrBJp9S6t09En5nw130_assertion wasGeneratedBy ECO_0000203 NP455470.RAFHG00pkcoKADfRNHvEqw8uHcCCfFrBJp9S6t09En5nw130_provenance.